Tag: Patients
Search News
New spinout launches to advance early pancreatic cancer detection
29th October 2025
Queen Mary University of London has launched a new company, Procyon Diagnostics, to provide pioneering early cancer detection tests. The company’s first test, PancRISK, offers new hope for detecting pancreatic cancer earlier, building on over 15 years of research by Professor Tatjana Crnogorac-Jurcevic at Queen Mary’s Barts Cancer Institute (BCI), funded by the Pancreatic Cancer Research Fund.
Read more
Breakthrough life-extending treatment for advanced bladder cancer available on NHS
21st August 2025
The new combination treatment offers hope to thousands of people living with advanced urothelial cancer. The clinical trials, led by Professor Tom Powles at Barts Cancer Institute, Queen Mary University of London, showed that overall survival rates were almost twice as long with this new treatment compared to the current standard treatment.
Read more
Pancreatic Cancer Research Fund Tissue Bank achieves landmark international accreditation
19th August 2025
The Pancreatic Cancer Research Fund Tissue Bank (PCRFTB) has become the first in England to receive ISO 20387:2018 accreditation, an international standard that recognises excellence in biobanking.
Read more
Could a breath test detect blood cancer?
23rd July 2025
Molecules exhaled in the breath may provide clues to detect blood cancer, according to new research by scientists at Barts Cancer Institute. The findings could enable the development of a blood cancer breathalyser, providing a rapid, low-cost way to detect disease.
Read more
Study reveals molecules enabling bowel cancer to hijack healing processes and spread
8th June 2025
Scientists have uncovered how bowel cancer cells imitate our gut’s natural healing processes to adapt, spread and grow. The findings researchers at Barts Cancer Institute could lead to new treatment strategies aimed at preventing cancer spread.
Read more
Scientists explore new way to bring CAR-T cell therapy to pancreatic cancer
22nd May 2025
A new strategy to help powerful cancer-targeting immune cells, known as CAR-T cells, infiltrate pancreatic tumours has been developed by researchers at Barts Cancer Institute, Queen Mary University of London. The unique three-pronged approach could pave the way for making CAR-T cell therapy—a treatment that has transformed care for certain blood cancers—effective against pancreatic cancer, a disease that remains very difficult to treat.
Read more